Fumonisin B1 exposure and its selective effect on porcine jejunal segment: Sphingolipids, glycolipids and trans-epithelial passage disturbance

Biochemical Pharmacology

Volumn 74, Issue 1, 2007, Pages 144-152

  Loiseau, Nicolas ^a   Debrauwer, Laurent ^b   Sambou, Tounkang ^a   Bouhet, Sandrine ^a   Miller, J David ^c   Martin, Pascal G ^a   Viadère, Jean Luc ^a   Pinton, Philippe ^a   Puel, Olivier ^a   Pineau, Thierry ^a   Tulliez, Jacques ^b   Galtier, Pierre ^a   Oswald, Isabelle P ^a  

^a CEMAGREF   (France)

^b CNRS   (France)

^c CARLETON UNIVERSITY   (Canada)

Author keywords

Fumonisin B1; Glycolipids; Intestinal epithelial cells; Sphingolipids; Swine; Trans epithelial flux

Indexed keywords

FUMONISIN; FUMONISIN B1; GLYCOLIPID; SPHINGANINE; SPHINGOLIPID; CARCINOGEN; DRUG DERIVATIVE; MYCOTOXIN; SAFINGOL; SPHINGOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRUSH BORDER; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; ILEUM; INTESTINE EPITHELIUM CELL; JEJUNUM; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SWINE; TISSUE INJURY; TRANSPORT KINETICS; ANIMAL; DOSE RESPONSE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CARCINOGENS, ENVIRONMENTAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FUMONISINS; GLYCOLIPIDS; INTESTINAL MUCOSA; JEJUNUM; MYCOTOXINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOSINE; SWINE;

EID: 34249001275     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.03.031     Document Type: Article

References (31)

1. Marasas W.F., Miller J.D., Riley R.T., and Visconti A. Fumonisine B1. International programme on chemistry safety (2000), Environmental Health Criteria, Geneva p. 43-50
2. Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives: World Health Organ Tech Rep Ser 2002. p. 16-26.
3. Haschek W.M., Gumprecht L.A., Smith G., Tumbleson M.E., and Constable P.D. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ Health Perspect 109 Suppl 2 (2001) 251-257
4. Bolger M., Coker R.D., Dinovi M., Gaylor D., Gelderblom M.O., Paster N., et al. Fumonisins. In: Food Additives WHO, and United Nations FAO (Eds). Safety evaluation of certain mycotoxins in food (2001) 103-279
5. Marasas W.F., Riley R.T., Hendricks K.A., Stevens V.L., Sadler T.W., Gelineau-van Waes J., et al. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 134 (2004) 711-716
6. Gelineau-van Waes J., Starr L., Maddox J., Aleman F., Voss K.A., Wilberding J., et al. Maternal fumonisin exposure and risk for neural tube defects: mechanisms in an in vivo mouse model. Birth Defects Res A Clin Mol Teratol 73 (2005) 487-497
7. Sadler T.W., Merrill A.H., Stevens V.L., Sullards M.C., Wang E., and Wang P. Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology 66 (2002) 169-176
8. Missmer S.A., Suarez L., Felkner M., Wang E., Merrill Jr. A.H., Rothman K.J., et al. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect 114 (2006) 237-241
9. Zheng W., Kollmeyer J., Symolon H., Momin A., Munter E., Wang E., et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758 (2006) 1864-1884
10. Wang E., Norred W.P., Bacon C.W., Riley R.T., and Merrill Jr. A.H. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 266 (1991) 14486-14490
11. Riley R.T., An N.H., Showker J.L., Yoo H.S., Norred W.P., Chamberlain W.J., et al. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol Appl Pharmacol 118 (1993) 105-112
12. Oswald I.P. Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res 37 (2006) 359-368
13. Prelusky D.B., Trenholm H.L., Rotter B.A., Miller J.D., Savard M.E., Yeung J.M., et al. Biological fate of fumonisin B1 in food-producing animals. Adv Exp Med Biol 392 (1996) 265-278
14. Shephard G.S., Thiel P.G., Stockenstrom S., and Sydenham E.W. Worldwide survey of fumonisin contamination of corn and corn-based products. J AOAC Int 79 (1996) 671-687
15. Enongene E.N., Sharma R.P., Bhandari N., Miller J.D., Meredith F.I., Voss K.A., et al. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. Toxicol Sci 67 (2002) 173-181
16. Schmelz E.M., Dombrink-Kurtzman M.A., Roberts P.C., Kozutsumi Y., Kawasaki T., and Merrill Jr. A.H. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol Appl Pharmacol 148 (1998) 252-260
17. Stevens V.L., and Tang J. Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem 272 (1997) 18020-18025
18. Miller J.D., Savard M.E., and Rapior S. Production and purification of fumonisins from a stirred jar fermenter. Nat Toxins 2 (1994) 354-359
19. Taranu I., Marin D.E., Bouhet S., Pascale F., Bailly J.D., Miller J.D., et al. Mycotoxin fumonisin B1 alters the cytokine profile and decreases the vaccinal antibody titer in pigs. Toxicol Sci 84 (2005) 301-307
20. Miller D., and Crane R.K. A procedure for the isolation of the epithelial brush border membrane of hamster small intestine. Anal Biochem 2 (1961) 284-286
21. Mano N., Oda Y., Yamada K., Asakawa N., and Katayama K. Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography/ionspray ionization tandem mass spectrometry. Anal Biochem 244 (1997) 291-300
22. Bouhet S., Hourcade E., Loiseau N., Fikry A., Martinez S., Roselli M., et al. The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicol Sci 77 (2004) 165-171
23. Bouchon B., and Portoukalian J. Purification of the peracetylated glycosphingolipids of the gala series (galactosyl- and galabiosylceramides). J Chromatogr 342 (1985) 385-392
24. Prelusky D.B., Miller J.D., and Trenholm H.L. Disposition of 14C-derived residues in tissues of pigs fed radiolabelled fumonisin B1. Food Addit Contam 13 (1996) 155-162
25. Murphy P.A., Rice L.G., and Ross P.F. Fumonisin-B1, fumonisin-b2, and fumonisin-b3 content of iowa, wisconsin, and illinois corn and corn screenings. J Agric Food Chem 41 (1993) 263-266
26. Gumprecht L.A., Beasley V.R., Weigel R.M., Parker H.M., Tumbleson M.E., Bacon C.W., et al. Development of fumonisin-induced hepatotoxicity and pulmonary edema in orally dosed swine: morphological and biochemical alterations. Toxicol Pathol 26 (1998) 777-788
27. Prelusky D.B., Trenholm H.L., and Savard M.E. Pharmacokinetic fate of 14C-labelled fumonisin B1 in swine. Nat Toxins 2 (1994) 73-80
28. Nusrat A., Parkos C.A., Verkade P., Foley C.S., Liang T.W., Innis-Whitehouse W., et al. Tight junctions are membrane microdomains. J Cell Sci 113 Pt 10 (2000) 1771-1781
29. Oswald I.P., Desautels C., Laffitte J., Fournout S., Peres S.Y., Odin M., et al. Mycotoxin fumonisin B1 increases intestinal colonization by pathogenic Escherichia coli in pigs. Appl Environ Microbiol 69 (2003) 5870-5874
30. Svensson M., Frendeus B., Butters T., Platt F., Dwek R., and Svanborg C. Glycolipid depletion in antimicrobial therapy. Mol Microbiol 47 (2003) 453-461
31. Stahl A., Hirsch D.J., Gimeno R.E., Punreddy S., Ge P., Watson N., et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 4 (1999) 299-308